Current stock page

Financial Data

QURE Financial Data

Revenue · Earnings · Margins · Balance Sheet · Cash Flow

HealthcareBiotechnologyScore data as of Nov 13, 2026

QUREuniQure N.V.

Healthcare / Biotechnology

Low Priority

Relative Laggard

BearishEdge 2/10
$23.81−$0.82 (−3.33%)

Latest quote

  • Momentum
    41
  • Value
    38
  • Quality
    42
  • Risk resilience
    31
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

Financial Data Overview

Detailed revenue, earnings, margins, balance sheet, cash flow, valuation metrics, technical indicators, and risk measures for deeper research.

Quarterly periods
8
Fundamental metrics
10
Technical indicators
12
Risk measures
6

Quarterly Financial Statements

Updated Nov 16, 2026.

Income statement
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Revenue$5.2M$5.84M$3.56M$5.57M$3.7M$5.26M$1.57M$5.22M
Gross Profit$4.96M-$4.55M$3.34M$2.16M$3.3M$4.61M$1.37M$4.6M
Operating Income-$52.98M-$55.89M-$44.27M-$52.16M-$51.04M-$43.87M-$39.33M-$45.83M
Net Income-$61.22M-$81.06M-$53.54M-$37.09M-$80.53M-$37.72M-$43.64M-$73.26M
EPS-$0.88-$1.22-$0.85-$0.59-$1.38-$0.69-$0.82-$1.5
Cash flow statement
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Operating Cash Flow-$47.83M-$28.58M-$38.24M-$77.57M-$16.4M-$39.9M-$44.1M-$52.84M
Capital Expenditure-$11K-$472K-$140K-$119K$66K-$260K-$126K-$61K
Free Cash Flow-$47.84M-$29.05M-$38.38M-$77.69M-$16.33M-$40.16M-$44.23M-$52.91M
Net Cash Provided By Operating Activities-$47.83M-$28.58M-$38.24M-$77.57M-$16.4M-$39.9M-$44.1M-$52.84M
Balance sheet
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Assets$940.55M$985.1M$778.71M$824.91M$888.38M$584.89M$605.4M$556.54M
Total Debt$62.37M$62.83M$63.32M$536.59M$66.16M$66.7M$66.2M$66.06M
Cash And Cash Equivalents$98.44M$413.03M$139.99M$80.24M$597.06M$253.78M$217.23M$158.93M
Total Liabilities$645.9M$661.05M$629.36M$626.01M$659.64M$588.89M$571.72M$563.29M
Total Stockholders Equity$294.65M$324.05M$149.34M$198.9M$228.75M-$4M$33.69M-$6.75M
Key financial metrics
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
P/E ratio————————
P/B ratio5.838.198.893.046.69—20.17—
P/S ratio82.53———————
Debt To Equity0.210.190.422.70.29—1.97—
Free Cash Flow Yield-11.20%-6.07%-12.96%-29.48%-10.04%-24.35%-25.87%-32.98%
Financial ratios
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
P/E ratio————————
P/B ratio5.838.198.893.046.69—20.17—
P/S ratio82.53———————
Return On Equity-79.04%-77.83%-139.86%-100.04%-102.80%—-6.46%—
Debt To Equity0.210.190.422.70.29—1.97—

Current Stock Metrics

Current fundamental, technical, and risk readings in one place.

Fundamental metrics
MetricValue
Pe-6.73x
Pb5.65x
Revenue Growth Yoy40.39%
EPS Growth Yoy36.23%
Gross Margin29.32%
Operating Margin-1017.97%
ROE-96.34%
ROIC-23.15%
Debt To Equity0.21
FCF Yield-11.55%

As of Nov 13, 2026

Technical indicators
MetricValue
Close$23.81
Volume1.39M
RSI (14)45.74
MACD-1.23
MACD signal-1.89
MACD histogram0.66
ADX (14)25.3
SMA (50)$29.50
SMA (200)$29.64
ATR (14)$1.86
Historical volatility (annualized)78.45%
Volume (20-day average)1.97M

As of Nov 13, 2026

Risk measures
MetricValue
Resilience score31/100
Beta0.68
Annual volatility132.25%
Max Drawdown-70.24%
Sharpe Ratio0.39
VaR (95%, 1-day)-7.66%

As of Nov 13, 2026

Detailed Metrics

Additional measures remain available here while the decision pages stay focused.

Additional fundamental metrics

No additional fundamental metrics are available.

Additional technical indicators

No additional technical indicators are available.

Additional risk measures

No additional risk measures are available.

QURE Financial Data FAQ

What is uniQure N.V.'s revenue?

uniQure N.V.'s revenue is one of the core financial data points for QURE. Use it with revenue growth, margins, and EPS to understand whether sales are translating into earnings power.

Is uniQure N.V.'s revenue growing?

Revenue growth shows whether uniQure N.V. is expanding from prior periods. Compare growth with margins and free cash flow because faster sales growth is more valuable when profitability holds up.

What is QURE's EPS?

QURE's EPS, or earnings per share, helps connect net income to each share. EPS should be compared with EPS growth, P/E ratio, and analyst expectations.

What is uniQure N.V.'s net income?

uniQure N.V.'s net income shows profit after costs, taxes, and other expenses. It should be read with revenue, operating margin, EPS, and free cash flow.

How much free cash flow does uniQure N.V. generate?

Free cash flow shows how much cash uniQure N.V. generates after capital spending. It is useful for judging reinvestment capacity, buybacks, debt reduction, and valuation support.

How much cash and debt does uniQure N.V. have?

Cash and debt help frame QURE's balance-sheet flexibility. Compare liquidity and leverage with free cash flow and profitability before judging financial strength.